Cargando…
Differential Inhibition of Human and Trypanosome Ubiquitin E1S by TAK-243 Offers Possibilities for Parasite Selective Inhibitors
Novel strategies to target Trypanosoma brucei, Trypanosoma cruzi and Leishmania are urgently needed to generate better and safer drugs against Human African Trypanosomiasis, Chagas disease and Leishmaniasis, respectively. Here, we investigated the feasibility of selectively targeting in trypanosomat...
Autores principales: | Boer, D. Roeland, Bijlmakers, Marie-José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838199/ https://www.ncbi.nlm.nih.gov/pubmed/31700050 http://dx.doi.org/10.1038/s41598-019-52618-3 |
Ejemplares similares
-
Targeting the Ubiquitin–Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer
por: Majeed, Safa, et al.
Publicado: (2022) -
GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma
por: Zhang, Xu, et al.
Publicado: (2022) -
A C2HC zinc finger is essential for the RING-E2 interaction of the ubiquitin ligase RNF125
por: Bijlmakers, Marie-José, et al.
Publicado: (2016) -
A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity
por: Barghout, Samir H., et al.
Publicado: (2021) -
Ubiquitination and the Proteasome as Drug Targets in Trypanosomatid Diseases
por: Bijlmakers, Marie-José
Publicado: (2021)